NCT05103215View on ClinicalTrials.gov

Lidocaine Infusion With ANI Monitoring in Spine Surgery.

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Spine Surgery
Interventions
DRUG

Lidocaine HCl 2%

Intravenous injection of 1.5 mg/kg lidocaine at induction of anesthesia and continuous infusion of 1.5 mg/kg/h (ideal body weight) through the maintenance period to one hour after operation.

DRUG

Normal saline

Intravenous injection of 1.5 mg/kg normal saline at induction of anesthesia and continuous infusion of 1.5 mg/kg/h (ideal body weight) through the maintenance period to one hour after operation.

Trial Locations (1)

Unknown

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER